EP
Eversept Partners’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Buy |
59,366
+1,877
| +3% | +$539K | 1.57% | 22 |
|
|
2025
Q1 | $17.7M | Buy |
57,489
+13,786
| +32% | +$4.25M | 1.8% | 18 |
|
|
2024
Q4 | $15.4M | Sell |
43,703
-87,246
| -67% | -$30.8M | 1.37% | 14 |
|
|
2024
Q3 | $46.9M | Sell |
130,949
-104,402
| -44% | -$37.4M | 3.21% | 12 |
|
|
2024
Q2 | $75M | Sell |
235,351
-15,784
| -6% | -$5.03M | 5.13% | 5 |
|
|
2024
Q1 | $57.7M | Buy |
251,135
+4,901
| +2% | +$1.13M | 3.85% | 7 |
|
|
2023
Q4 | $54.1M | Sell |
246,234
-21,669
| -8% | -$4.76M | 4.76% | 6 |
|
|
2023
Q3 | $60.5M | Buy |
267,903
+7,505
| +3% | +$1.7M | 5.12% | 4 |
|
|
2023
Q2 | $57.5M | Buy |
260,398
+38,291
| +17% | +$8.45M | 4.81% | 4 |
|
|
2023
Q1 | $49.7M | Sell |
222,107
-10,680
| -5% | -$2.39M | 3.47% | 5 |
|
|
2022
Q4 | $64.7M | Sell |
232,787
-22,439
| -9% | -$6.24M | 5.67% | 5 |
|
|
2022
Q3 | $53.4M | Sell |
255,226
-55,608
| -18% | -$11.6M | 4.63% | 5 |
|
|
2022
Q2 | $73.2M | Buy |
310,834
+18,600
| +6% | +$4.38M | 5.21% | 2 |
|
|
2022
Q1 | $52.4M | Sell |
292,234
-99,686
| -25% | -$17.9M | 4.03% | 5 |
|
|
2021
Q4 | $84.7M | Sell |
391,920
-52,551
| -12% | -$11.4M | 5.41% | 3 |
|
|
2021
Q3 | $82M | Buy |
444,471
+1,526
| +0.3% | +$282K | 5.67% | 1 |
|
|
2021
Q2 | $79.5M | Sell |
442,945
-43,584
| -9% | -$7.82M | 5.3% | 1 |
|
|
2021
Q1 | $81.4M | Buy |
486,529
+27,893
| +6% | +$4.67M | 6.12% | 2 |
|
|
2020
Q4 | $69.6M | Buy |
458,636
+217,732
| +90% | +$33M | 8.17% | 2 |
|
|
2020
Q3 | $24.3M | Buy |
240,904
+8,228
| +4% | +$831K | 5.41% | 5 |
|
|
2020
Q2 | $28.2M | Buy |
+232,676
| New | +$28.2M | 3.86% | 7 |
|